pocketful logo light
pocketful logo light
Jenburkt Pharmaceuticals Ltd logo

Jenburkt Pharmaceuticals Ltd

NSE: BSE: 524731

₹1003.90

(2.23%)

Sat, 12 Sept 2026, 08:28 am

mtf coin illustrationMTF 5x

Jenburkt Pharmaceuticals Share Price Live Chart

1 Day

(2.23%)

No Result Found

Summary

  • Market Cap (in Cr)

    508.06

  • Net Profit (in Cr)

    32.06

  • P/B

    2.60

  • Sector P/E

    44.89

  • P/E

    13.93

  • EV/EBITDA

    9.04

  • Debt/Equity (Industry)

    0.26

  • Interest Cover (Industry)

    10.81

  • ROCE (Industry)

    16.40

  • RONW (Industry)

    14.39

  • ROE

    20.25

  • ROCE

    27.18

  • Debt/Equity

    0.01

  • EPS (TTM)

    85.23

  • Dividend Yield

    1.80

  • Book Value

    446.48

  • Interest Cover

    98.62

Analysis

No Result Found

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters46.6446.6546.6646.6746.68
FII00000
DII0.120.120.120.120.12
Public53.2553.2453.2253.2253.20
Government00000

Read More

Technical Analysis

RSI

37.29

MACD

-11.83

50 DMA

1069.60

200 DMA

1081.91

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic1561.101330.101190.201099.10959.20868.10637.10
Fibonacci1330.101241.861187.341099.101010.86956.34868.10
Camarilla1113.831092.651071.471099.101029.131007.95986.77

Pivots Level: Classic

R3

+462

1561.10

R2

+231

1330.10

R1

+91.10

1190.20

1099.10
1099.10
Pivot Point
LTP: 1006.70

S1

-139.90

959.20

S2

-231

868.10

S3

-462

637.10

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    1036.63

  • 20-EMA

    1045.35

  • 30-EMA

    1053.52

  • 50-EMA

    1066.33

  • 100-EMA

    1079.97

  • 200-EMA

    1090.14

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
05 May 2026agm
05 May 2026board-meetingsQuarterly Results, Dividend
03 Feb 2026board-meetingsQuarterly Results
11 Jun 2025dividendFinal Dividend - Rs. - 1811 Jul 2025
20 May 2025agm
20 May 2025dividend₹18.00 Dividend /Share11 Jul 2025
28 May 2024dividend₹15.30 Dividend /Share24 Jul 2024
28 May 2024agm
23 May 2023dividend₹14.40 Dividend /Share20 Jul 2023
23 May 2023agm

Read More

Peer Comparison

Jenburkt Pharmaceuticals Ltd logo

Jenburkt Pharmaceuticals Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Cipla Ltd logo

Cipla Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Read More

Jenburkt Pharmaceuticals Ltd About

Jenburkt Pharmaceuticals is in the business of manufacturing, producing, developing and marketing a wide range of branded Pharmaceuticals and health care products. (Source : 202503 Annual Report Page No: 57)

Industry

Pharmaceuticals - Indian - Formulations

Founded

1985

Headquarters

CEO

Ashish U Bhuta

Employees

Contact

Website icon

Website

http://www.jenburkt.com

Email icon

Email

investor@jenburkt.com

Phone icon

Phone

91-22-66943121/67603603

Location icon

Location

Nirmala Apartment P B No 37396, 93 Jayprakash Road Andheri(W), Mumbai, Maharashtra, 400058

Read More

Jenburkt Pharmaceuticals Ltd Company History

YearHistory
2012
  • Jenburkt Pharmaceuticals Ltd has recommended a dividend of Rs. 3.50 (35%) per equity share of Rs. 10/- each.
2013
  • Shri. Ashish U. Bhuta has been appointed as the Chairman and Managing Director of the Company
2014
  • The Company has recommended a Dividend of Rs. 5.10 (51%) per equity share of Rs. 10/- each.
  • Ms. Devangi Sanjeev Shah has been appointed as Woman Director
2020
  • Jenburkt launched Favipiravir (Favivent) to fight COVID-19
2022
  • The Company Launched a new product ZIXA STRONG on e-commerce websites.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
JENBURKT PHARMACEUTICALS LTDbulkBuy47037649.9706 Jan 2023
ARIES STOCKTRADES PVT LTD A/C-PMSbulkSell26000410.3925 Aug 2020
TRUPTI KETAN KARANIbulkSell26000540.508 Feb 2018
KETAN JAYANTILAL KARANI (HUF)bulkBuy26000540.508 Feb 2018
RAJASTHAN GLOBAL SECURITIES PRIVATE LIMITEDbulkBuy2388746524 Oct 2017
GIRIK WEALTH ADVISORS PRIVATE LIMITED-DEEP VALUE PMSbulkSell30794433.2605 Sept 2017
Aries Stocktrades Pvt Ltd A/c-PMSbulkBuy23591566.6704 Nov 2016
KAUSHIK PARASKUMAR DAGAbulkBuy30000347.1230 Jan 2015
DINERO WEALTH ADVISORS PRIVATE LIMITEDbulkSell30000347.0330 Jan 2015
DINERO WEALTH ADVISORS PRIVATE LIMITEDbulkBuy28646187.9530 Jul 2014

Read More

Jenburkt Pharmaceuticals Ltd News

Jenburkt Pharmaceuticals closes trading window

Jenburkt Pharmaceuticals Ltd closed its trading window from July 1, 2026, until 48 hours after Q1FY27 results are released.

18 Jun 2026

companies

Jenburkt Pharma Files FY26 Audited Results Under Reg 33

Jenburkt Pharmaceuticals published standalone audited financial results for Q4 and FY26 ended March 31, 2026, approved by the Board on May 5, 2026.

06 May 2026

companies

Jenburkt Pharmaceuticals confirms 'not a large corporate' status for FY26

Jenburkt Pharmaceuticals Limited disclosed to BSE that it maintains 'not a large corporate' status for financial year ended March 31, 2026, as per SEBI regulatory requirements.

14 Apr 2026

companies

Jenburkt Pharma Files Q4 FY26 Compliance Certificate

Jenburkt Pharmaceuticals submits mandatory quarterly certificate to BSE confirming compliance with SEBI dematerialization regulations for Q4 FY26 period ended March 31, 2026.

07 Apr 2026

companies

Jenburkt Pharmaceuticals Q3FY26 Results

Jenburkt Pharmaceuticals reported Q3FY26 revenue of Rs 4302.39 lacs and net profit of Rs 593.14 lacs. Nine-month revenue reached Rs 12410.83 lacs with profit of Rs 2388.66 lacs.

03 Feb 2026

co actions results

Read More

Frequently Asked Questions

  • 1.What is the stock price of Jenburkt Pharmaceuticals Ltd?

    As of 12/09/2026 at 1:58 PM, Jenburkt Pharmaceuticals Ltd shares are trading at ₹1003.90.

  • 2.What is the market cap. of Jenburkt Pharmaceuticals Ltd?

    As of 12/09/2026, the market capitalization of Jenburkt Pharmaceuticals Ltd is ₹458.28 crore.

  • 3.When was Jenburkt Pharmaceuticals Ltd founded?

    Jenburkt Pharmaceuticals Ltd was founded in 1985.

  • 4.What are the P/E and P/B ratios of Jenburkt Pharmaceuticals Ltd?

    As of 12/09/2026, Jenburkt Pharmaceuticals Ltd has a P/E ratio of 13.50 and a P/B ratio of 2.60.

  • 5.How can I buy shares of Jenburkt Pharmaceuticals Ltd?

    You can buy shares of Jenburkt Pharmaceuticals Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.

  • 6.Does Jenburkt Pharmaceuticals Ltd pay dividends?

    Yes, Jenburkt Pharmaceuticals Ltd pays dividends to eligible shareholders. The latest dividend announced by the company was ₹Final Dividend - Rs. - 18 per share.

  • 7.What is the dividend yield of Jenburkt Pharmaceuticals Ltd?

    As of 12 September, 2026, the dividend yield of Jenburkt Pharmaceuticals Ltd stands at 1.99%.

  • 8.What are the latest financial results of Jenburkt Pharmaceuticals Ltd?

    For January,2024, Jenburkt Pharmaceuticals Ltd reported revenue of ₹152.00 crore and a net profit of ₹32.06 crore.

  • 9.Who is the CEO of Jenburkt Pharmaceuticals Ltd?

    The CEO of Jenburkt Pharmaceuticals Ltd is Ashish U Bhuta.

Open Your Free Demat Account

Enter your phone number